batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Targeted bladder cancer treatment evolves 23 January 2024 ASCO-GI – early casdozokitug celebration for Coherus 22 January 2024 Trodelvy throws second-line lung cancer another curveball 22 January 2024 ASCO-GI – Novartis looks for earlier Lutathera use 19 January 2024 ASCO-GI – investors want a better look before they Leap 18 January 2024 Patent invalidation restores the Daiichi status quo 18 January 2024 ASCO-GI – Jacobio’s KRAS looks competitive in pancreatic 17 January 2024 Ifinatamab goes pivotal 15 January 2024 Load More